⌘K

Login Start Free

Home/Filings/4/0001209191-23-050613

4//SEC Filing

Dupont Jakob 4

Accession 0001209191-23-050613

CIK 0001782223other

View on SEC.gov Company Profile

Filed

Sep 25, 8:00 PM ET

Accepted

Sep 26, 7:04 PM ET

Size

5.4 KB

Accession

0001209191-23-050613

Insider Transaction Report

Form 4

Period: 2023-09-22

Pyxis Oncology, Inc.PYXS

Director

Transactions

Award
Stock Option (Right to Buy)
2023-09-22+392,461→ 392,461 total
Exercise: $1.60Exp: 2033-09-22→ Common Stock (392,461 underlying)

Footnotes (1)

[F1]These stock options vest in three equal annual installments beginning on the first anniversary of August 23, 2023, subject to the reporting person's continued service through the applicable vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Pyxis Oncology, Inc.

CIK 0001782223

Entity typeother

Related Parties

1

filerCIK 0001553335

Filing Metadata

Form type: 4
Filed: Sep 25, 8:00 PM ET
Accepted: Sep 26, 7:04 PM ET
Size: 5.4 KB

View on SEC.gov